These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 792494)

  • 1. Effect of cephalothin on growth patterns of micro-organisms.
    Bodey GP; Pan T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1092-5. PubMed ID: 792494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of cephalosporins.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1976 Feb; 29(2):181-6. PubMed ID: 6411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Larsson P; Lincoln K; Lind L; Sandberg T
    Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal forms of bacteria produced by antibiotics.
    Lorian V; Atkinson B
    Am J Clin Pathol; 1975 Nov; 64(5):678-88. PubMed ID: 242211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concept of class in relation to first-generation cephalosporins].
    De Toffoli A; Fantin B; Vechiet D
    Quad Sclavo Diagn; 1984 Jun; 20(2):181-6. PubMed ID: 6441962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of cephalothin and cephalexin on various bacterial species isolated from biological material in the Regional Hygienic Station Bratislava].
    Simkovicová M; Hausmannová Z; Sobotová Z
    Cas Lek Cesk; 1976 May; 115(20-21):612-6. PubMed ID: 776399
    [No Abstract]   [Full Text] [Related]  

  • 12. [Time factors in the bactericidal activity of gentamycin against E. coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas pyoceanea and Staphylococcus aureus].
    Helm E; Shah PM; Stille W
    Med Welt; 1974 Apr; 25(15):644-8. PubMed ID: 4596609
    [No Abstract]   [Full Text] [Related]  

  • 13. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
    Kosmidis J; Hamilton-Miller JM; Gilchrist JN; Kerry DW; Brumfitt W
    Br Med J; 1973 Dec; 4(5893):653-5. PubMed ID: 4202265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.
    Lingaas E; Midtvedt T; Melby K; Dahl OU
    Chemotherapy; 1981; 27(4):239-46. PubMed ID: 7249786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro and in vivo antibacterial activity of cephapirin (author's transl)].
    Mitsuhashi S; Yaginuma S; Ono H; Kurashige S
    Jpn J Antibiot; 1974 Apr; 27(2):152-6. PubMed ID: 4211466
    [No Abstract]   [Full Text] [Related]  

  • 16. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. II].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jun; 38(6):1587-602. PubMed ID: 3900459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New cephalosporin antibiotic: cephapirin].
    Urbinati G
    Clin Ter; 1977 Mar; 80(5):491-9. PubMed ID: 322931
    [No Abstract]   [Full Text] [Related]  

  • 19. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.